2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
74
Breast Neoplasms
70
Rectal Neoplasms
51
Stomach Neoplasms
45
Glioblastoma
45
Esophageal Neoplasms
41
Colorectal Neoplasms
37
Lung Neoplasms
35
Brain Neoplasms
35
Squamous Cell Carcinoma of Head and Neck
32
Pancreatic Neoplasms
31
Glioma
27
Neoplasms
26
Sarcoma
23
Neoplasm Metastasis
23
Astrocytoma
22
Head and Neck Neoplasms
21
Carcinoma, Hepatocellular
18
Esophageal Squamous Cell Carcinoma
16
Colonic Neoplasms
16
Recurrence
15
Ovarian Neoplasms
15
Melanoma
15
Gliosarcoma
15
Central Nervous System Neoplasms
15
Urinary Bladder Neoplasms
13
Oligodendroglioma
13
Uterine Cervical Neoplasms
12
Adenocarcinoma Of Esophagus
12
Prostatic Neoplasms
11
Interventions
pertuzumab
1
pazopanib
1
enzalutamide
1
delta 24-sterol reductase
1
decitabine and cedazuridine drug combination
1
daratumumab
1
apalutamide
1
Validation Studies as Topic
1
Trastuzumab
1
Tape Recording
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Risk Assessment
1
Radiotherapy
1
Preoperative Exercise
1
Pilot Projects
1
Opdualag
1
Nutritional Support
1
Nivolumab
1
Injections, Subcutaneous
1
Focus Groups
1
Exercise
1
Ethanol
1
Bandages, Hydrocolloid
1
Ado-Trastuzumab Emtansine
1
Adiposity
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Preference
×
Surgical Procedures, Operative
×
Clear all
NCT05415215
2026-02-10
ProHer
Hoffmann-La Roche
Phase 3
Completed
346 enrolled
20 charts